References
- Weng TI, Chin LW, Chen LY, et al. Clinical characteristics of patients admitted to emergency department for the use of ketamine analogues with or without other new psychoactive substances. Clin Toxicol. 2021;59(6):528–531.
- Allard S, Allard PM, Morel I, et al. Application of a molecular networking approach for clinical and forensic toxicology exemplified in three cases involving 3-MeOPCP, doxylamine, and chlormequat. Drug Test Anal. 2019;11(5):669–677.
- Vincenti F, Montesano C, Di OF, et al. Molecular networking: a useful tool for the identification of new psychoactive substances in seizures by LC-HRMS. Front Chem. 2020;8:572952.
- Berar A, Allain J-S, Allard S, et al. Intoxication with 3- MeO-PCP alone: a case report and literature review. Medicine (Baltimore). 2019;98(52):e18295.
- Dunlop LC, Wood D, Archer J, et al. Severe toxicity to the new psychoactive substances 3-hydroxyphencyclidine and N-ethylhexedrone: an analytically confirmed case report. J Med Toxicol. 2020;16(1):67–70.